Taditional Chinese Medicine (TCM) for COVID-
19 Market
Taditional Chinese Medicine (TCM) for COVID-19
Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Taditional Chinese Medicine (TCM) for COVID-19
Market Size and Growth
Traditional Chinese Medicine (TCM) has gained traction as a potential treatment for COVID-19 due to its holistic approach and symptom-targeted remedies. Market research indicates a growing demand for TCM products worldwide, with a projected market size of $XX billion by 2025. This trend is driven by a shift towards natural and alternative treatments in the wake of the pandemic.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Yiling Pharmaceutical
◍ Southwest Pharmaceutical
◍ Guizhou Yibai Pharmaceutical
◍ Tianjin Chase Sun Pharmaceutical
◍ Qingfeng Pharmaceutical Group
◍ Sunflower
The Traditional Chinese Medicine (TCM) for COVID-19 Market is highly competitive with companies like Yiling Pharmaceutical, Southwest Pharmaceutical, and Beijing Tong Ren Tang Group leading the way. These companies utilize TCM through herbal remedies and traditional practices to treat COVID-19 patients, helping to grow the market.
- Yiling Pharmaceutical: $2.1 billion
- Beijing Tong Ren Tang Group Co., Ltd.: $1.8 billion
- Guangzhou Pharmaceuticals Corporation: $1.4 billion
◍ China Beijing Tong Ren Tang Group Co., Ltd.
◍ Jiren Pharmaceutical Group
◍ Beijing Juxiechang Pharmaceutical
◍ Jiuzhitang
◍ Jiangsu Jichuan Holding Group Co., Ltd.
Market Segmentation
By Application
Hospital
Clinic ◍ Other
By Product
◍ Lianhua Qingwen Capsule
◍ Jinhua Qinggan Granules
◍ Xuebijing Injection
◍ TCM Prescription ◍ Other
Market Growth
Request Sample Report
$ X Billion USD
